Want tender expert help? See our tender preparation service
Tenders

Pantoprazole IV in the form of a framework agreement

Open

Updated November 06, 2026

Deadline
31 days left
December 08, 2026
Contract Details
Category
Other
Reference
POCHRV2026PANTO122
Value
Not disclosed
Location
BE335, Belgium
Published
October 30, 2026
CPV Code
Project Timeline

Tender Published

November 06, 2026

Deadline for Questions

December 01, 2026

Submission Deadline

December 08, 2026

Key facts

Deadline
31 days left
CPV Code
33600000-6 — Pharmaceutical products
Budget
Not disclosed
Duration
6 months
Location
BE335
Type
Other

Original Tender Description

la fourniture de pantoprazole IV (40 mg)

Risk Analysis

Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Login

Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

9 documents available with AI summaries

Avis de marché (publicprocurement.be)DOC

No summary available for this document.

PO-CHRV2026-PANTO-122-Annexe A-FO.docxDOC
PO-CHRV2026-PANTO-122-Annexe A-FO.docx

No summary available for this document.

PO-CHRV2026-PANTO-122-Annexe B-Inventaire.docxDOC
PO-CHRV2026-PANTO-122-Annexe B-Inventaire.doc...

No summary available for this document.

PO-CHRV2026-PANTO-122-Annexe C-Critères d'attribution.docxDOC
PO-CHRV2026-PANTO-122-Annexe C-Critères d'att...

No summary available for this document.

PO-CHRV2026-PANTO-122 - Annexe D - Liste des excipients à effet notoire.pdfPDF
PO-CHRV2026-PANTO-122 - Annexe D - Liste des ...

No summary available for this document.

PO-CHRV2026-PANTO-122-Annexe E-Exigences tech.xlsxXLS
PO-CHRV2026-PANTO-122-Annexe E-Exigences tech...

No summary available for this document.

PO-CHRV2026-PANTO-122 - Annexe F Crit Sél.xlsxXLS
PO-CHRV2026-PANTO-122 - Annexe F Crit Sél.xls...

No summary available for this document.

PO-CHRV2026-PANTO-122 - Annexe G - points de contact Marchés pharma.docxDOC
PO-CHRV2026-PANTO-122 - Annexe G - points de ...

No summary available for this document.

PO CHRV2026 PANTO 122- CSC PANTOPRAZOLE.pdfPDF
PO CHRV2026 PANTO 122- CSC PANTOPRAZOLE.pdf

No summary available for this document.

Documents Preview

Sign up to view document summaries and analysis

Quality Score

Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.

Login